NIOX Group (LON:NIOX) Stock Price Up 1.4% - Still a Buy?

Key Points

• NIOX Group Plc shares increased by 1.4%, reaching GBX 73.40 ($0.99), significantly above the previous close of GBX 72.40 ($0.98).
• The company's market capitalization is approximately £306.68 million, with a notably high PE ratio of 8,843.37.
• Insider Ian Johnson bought 144,844 shares at an average price of GBX 8, reflecting continued confidence in the firm.

Shares of NIOX Group Plc (LON:NIOX - Get Free Report) were up 1.4% during mid-day trading on Thursday . The stock traded as high as GBX 74 ($1.00) and last traded at GBX 73.40 ($0.99). Approximately 6,608,950 shares traded hands during mid-day trading, an increase of 503% from the average daily volume of 1,096,099 shares. The stock had previously closed at GBX 72.40 ($0.98).

NIOX Group Trading Up 0.3%

The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.94 and a current ratio of 6.31. The company has a 50 day moving average of GBX 70.67 and a two-hundred day moving average of GBX 67.92. The stock has a market cap of £307.52 million, a PE ratio of 8,867.47 and a beta of 0.92.

Insider Buying and Selling

In related news, insider Ian Johnson bought 144,844 shares of the stock in a transaction dated Wednesday, June 25th. The shares were acquired at an average cost of GBX 8 per share, for a total transaction of £11,587.52. Company insiders own 4.89% of the company's stock.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings. Headquartered in the UK and listed on the London Stock Exchange ticker: NIOX, the company operates internationally, serving healthcare professionals in over 50 countries.